The Relationship between Virus Replication and Host Gene Expression in Lymphatic Tissue during HIV-1 Infection - GSE21589
During HIV-1 infection, there is a massive perturbation of host gene expression, but as yet, genome-wide studies have not identified host genes affecting HIV-1 replication in lymphatic tissue, the primary site of virus-host interactions. In this study, we isolated RNA from the inguinal lymph nodes of 22 HIV-1-infected individuals and utilized a microarray approach to identify host genes critically important for viral replication in lymphatic tissue by examining gene expression associated with viral load. Strikingly, ~95% of the transcripts (558) in this data set (592 transcripts total) were negatively associated with HIV-1 replication. Genes in this subset (1) inhibit cellular activation/proliferation (ex.: TCFL5, SOCS5 and SCOS7, KLF10), (2) promote heterochromatin formation (ex.: HIC2, CREBZF, ZNF148/ZBP-89), (3) increase collagen synthesis (ex.: PLOD2, POSTN, CRTAP), and (4) reduce cellular transcription and translation. Potential anti-HIV-1 restriction factors were also identified (ex.: NR3C1, HNRNPU, PACT). Only ~5% of the transcripts (34) were positively associated with HIV-1 replication. Paradoxically, nearly all these genes function in innate and adaptive immunity, particularly highlighting a heightened interferon system. The predominance of negative correlations as well as the disconnect between host defenses and viral load point to the importance of genes that regulate target cell activation and genes that code for potentially new restriction factors as determinants of viral load rather than conventional host defenses.
--
Total RNA was isolated from the inguinal lymph nodes of 22 HIV-1-infected subjects at different clinical stages (and varying viral loads) and prepared for RNA extraction and hybridization on Affymetrix Human Genome U133 Plus 2.0 microarrays. Replicate arrays were performed for lymph node samples to minimize assay noise and host genes critically important for viral replication in lymphatic tissue were identified by examining gene expression and its association with viral load. Replicates were not performed for samples WB91 and TS35 due to limited amounts of biomaterial.
--
--
--
--
Sample ID | Age | Gender | !Sample_title | tissue | race |
---|---|---|---|---|---|
GSM538932 | 41 | Male | DP24a | Inguinal lymph node | Caucasian |
GSM538933 | 41 | Male | DP24b | Inguinal lymph node | Caucasian |
GSM538934 | 26 | Male | JS30a | Inguinal lymph node | Caucasian |
GSM538935 | 26 | Male | JS30b | Inguinal lymph node | Caucasian |
GSM538936 | 51 | Male | MH58a | Inguinal lymph node | Caucasian |
File |
---|
All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.
Sample ID | Age | Gender | !Sample Title | Tissue | Race | Peripheral blood cd4+ t cells (cells/ml) | Plasma hiv-1 rna levels (copies/ml) |
---|---|---|---|---|---|---|---|
GSM538932 | 41 |
Male |
DP24a |
Inguinal lymph node |
Caucasian |
494 |
14,696 |
GSM538933 | 41 |
Male |
DP24b |
Inguinal lymph node |
Caucasian |
494 |
14,696 |
GSM538934 | 26 |
Male |
JS30a |
Inguinal lymph node |
Caucasian |
683 |
03,610 |
GSM538935 | 26 |
Male |
JS30b |
Inguinal lymph node |
Caucasian |
683 |
03,610 |
GSM538936 | 51 |
Male |
MH58a |
Inguinal lymph node |
Caucasian |
400 |
439,000 |
GSM538937 | 51 |
Male |
MH58b |
Inguinal lymph node |
Caucasian |
400 |
439,000 |
GSM538938 | 32 |
Male |
PR89a |
Inguinal lymph node |
Caucasian |
824 |
32,173 |
GSM538939 | 32 |
Male |
PR89b |
Inguinal lymph node |
Caucasian |
824 |
32,173 |
GSM538940 | 23 |
Male |
WB55a |
Inguinal lymph node |
African American |
209 |
19,400 |
GSM538941 | 23 |
Male |
WB55b |
Inguinal lymph node |
African American |
209 |
19,400 |
GSM538942 | 37 |
Male |
WB91a |
Inguinal lymph node |
African American |
234 |
24,718 |
GSM538943 | 59 |
Male |
PH29a |
Inguinal lymph node |
Caucasian |
370 |
484,694 |
GSM538944 | 59 |
Male |
PH29b |
Inguinal lymph node |
Caucasian |
370 |
484,694 |
GSM538945 | 30 |
Male |
TH49a |
Inguinal lymph node |
Caucasian |
333 |
100,000 |
GSM538946 | 30 |
Male |
TH49b |
Inguinal lymph node |
Caucasian |
333 |
100,000 |
GSM538947 | 42 |
Male |
TS35a |
Inguinal lymph node |
Caucasian |
663 |
100,000 |
GSM538948 | 34 |
Male |
JR31a |
Inguinal lymph node |
Caucasian |
333 |
71,200 |
GSM538949 | 34 |
Male |
JR31b |
Inguinal lymph node |
Caucasian |
333 |
71,200 |
GSM538950 | 23 |
Male |
CF63a |
Inguinal lymph node |
African American |
259 |
27,200 |
GSM538951 | 23 |
Male |
CF63b |
Inguinal lymph node |
African American |
259 |
27,200 |
GSM538952 | 32 |
Male |
DS35a |
Inguinal lymph node |
Caucasian |
400 |
15,284 |
GSM538953 | 32 |
Male |
DS35b |
Inguinal lymph node |
Caucasian |
400 |
15,284 |
GSM538954 | 34 |
Male |
KS64a |
Inguinal lymph node |
Caucasian |
202 |
122,000 |
GSM538955 | 34 |
Male |
KS64b |
Inguinal lymph node |
Caucasian |
202 |
122,000 |
GSM538956 | 49 |
Male |
RJ56a |
Inguinal lymph node |
Caucasian |
478 |
174,000 |
GSM538957 | 49 |
Male |
RJ56b |
Inguinal lymph node |
Caucasian |
478 |
174,000 |
GSM538958 | 63 |
Male |
SU36a |
Inguinal lymph node |
Caucasian |
248 |
46,400 |
GSM538959 | 63 |
Male |
SU36b |
Inguinal lymph node |
Caucasian |
248 |
46,400 |
GSM538960 | 36 |
Male |
WU59a |
Inguinal lymph node |
Caucasian |
286 |
100,000 |
GSM538961 | 36 |
Male |
WU59b |
Inguinal lymph node |
Caucasian |
286 |
100,000 |
GSM538962 | 39 |
Male |
RM08a |
Inguinal lymph node |
Caucasian |
685 |
20,014 |
GSM538963 | 39 |
Male |
RM08b |
Inguinal lymph node |
Caucasian |
685 |
20,014 |
GSM538964 | 35 |
Male |
TK07a |
Inguinal lymph node |
Caucasian |
372 |
31,922 |
GSM538965 | 35 |
Male |
TK07b |
Inguinal lymph node |
Caucasian |
372 |
31,922 |
GSM538966 | 49 |
Male |
GL38a |
Inguinal lymph node |
Caucasian |
147 |
04,960 |
GSM538967 | 49 |
Male |
GL38b |
Inguinal lymph node |
Caucasian |
147 |
04,960 |
GSM538968 | 43 |
Male |
TK62a |
Inguinal lymph node |
Caucasian |
81 |
35,000 |
GSM538969 | 43 |
Male |
TK62b |
Inguinal lymph node |
Caucasian |
81 |
35,000 |
GSM538970 | 40 |
Female |
VM27a |
Inguinal lymph node |
African American |
112 |
12,046 |
GSM538971 | 40 |
Female |
VM27b |
Inguinal lymph node |
African American |
112 |
12,046 |
GSM538972 | 45 |
Male |
OB06a |
Inguinal lymph node |
African American |
188 |
10,684 |
GSM538973 | 45 |
Male |
OB06b |
Inguinal lymph node |
African American |
188 |
10,684 |
Name | ||
---|---|---|
All Samples | Default | View |
In order to make new Group Sets or change settings, please log in. |
Group Set | |
---|---|
All Samples |